BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 34037380)

  • 1. CRISPR-Cas13 System as a Promising and Versatile Tool for Cancer Diagnosis, Therapy, and Research.
    Palaz F; Kalkan AK; Can Ö; Demir AN; Tozluyurt A; Özcan A; Ozsoz M
    ACS Synth Biol; 2021 Jun; 10(6):1245-1267. PubMed ID: 34037380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-Cas13 Precision Transcriptome Engineering in Cancer.
    Granados-Riveron JT; Aquino-Jarquin G
    Cancer Res; 2018 Aug; 78(15):4107-4113. PubMed ID: 30021724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cas13d: A New Molecular Scissor for Transcriptome Engineering.
    Gupta R; Ghosh A; Chakravarti R; Singh R; Ravichandiran V; Swarnakar S; Ghosh D
    Front Cell Dev Biol; 2022; 10():866800. PubMed ID: 35433685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of CRISPR/Cas13-Based RNA Editing in Plants.
    Kavuri NR; Ramasamy M; Qi Y; Mandadi K
    Cells; 2022 Aug; 11(17):. PubMed ID: 36078073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of the versatile CRISPR-Cas13 RNA targeting system.
    Kordyś M; Sen R; Warkocki Z
    Wiley Interdiscip Rev RNA; 2022 May; 13(3):e1694. PubMed ID: 34553495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review on CRISPR/Cas: a versatile tool for cancer screening, diagnosis, and clinic treatment.
    Yang X; Zhang B
    Funct Integr Genomics; 2023 May; 23(2):182. PubMed ID: 37231285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering CRISPR/Cas13 System against RNA Viruses: From Diagnostics to Therapeutics.
    Xue Y; Chen Z; Zhang W; Zhang J
    Bioengineering (Basel); 2022 Jun; 9(7):. PubMed ID: 35877342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programmable RNA targeting with CRISPR-Cas13.
    Shi P; Wu X
    RNA Biol; 2024 Jan; 21(1):1-9. PubMed ID: 38764173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mini review: genome and transcriptome editing using CRISPR-cas systems for haematological malignancy gene therapy.
    Elliott EK; Haupt LM; Griffiths LR
    Transgenic Res; 2021 Apr; 30(2):129-141. PubMed ID: 33609253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CASowary: CRISPR-Cas13 guide RNA predictor for transcript depletion.
    Krohannon A; Srivastava M; Rauch S; Srivastava R; Dickinson BC; Janga SC
    BMC Genomics; 2022 Mar; 23(1):172. PubMed ID: 35236300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional Features and Current Applications of the RNA-Targeting Type VI CRISPR-Cas Systems.
    Perčulija V; Lin J; Zhang B; Ouyang S
    Adv Sci (Weinh); 2021 Jul; 8(13):2004685. PubMed ID: 34254038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-Cas13 technology portfolio and alliance with other genetic tools.
    Wu S; Tian P; Tan T
    Biotechnol Adv; 2022 Dec; 61():108047. PubMed ID: 36208845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery, classification and application of the CPISPR-Cas13 system.
    Nie X; Wang D; Pan Y; Hua Y; Lü P; Yang Y
    Technol Health Care; 2024; 32(2):525-544. PubMed ID: 37545273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The double life of CRISPR-Cas13.
    Bot JF; van der Oost J; Geijsen N
    Curr Opin Biotechnol; 2022 Dec; 78():102789. PubMed ID: 36115160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in CRISPR-Cas systems for RNA targeting, tracking and editing.
    Wang F; Wang L; Zou X; Duan S; Li Z; Deng Z; Luo J; Lee SY; Chen S
    Biotechnol Adv; 2019; 37(5):708-729. PubMed ID: 30926472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas Systems towards Next-Generation Biosensing.
    Li Y; Li S; Wang J; Liu G
    Trends Biotechnol; 2019 Jul; 37(7):730-743. PubMed ID: 30654914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Cas13 in malaria parasite: Diagnosis and prospective gene function identification.
    Quansah E; Chen Y; Yang S; Wang J; Sun D; Zhao Y; Chen M; Yu L; Zhang C
    Front Microbiol; 2023; 14():1076947. PubMed ID: 36760507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alleviation of neurological disease by RNA editing.
    Zhang S; Chen L; Zhang Y; Fang D
    Methods; 2021 Oct; 194():94-99. PubMed ID: 33933604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA-Targeting CRISPR-Cas Systems and Their Applications.
    Burmistrz M; Krakowski K; Krawczyk-Balska A
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A versatile toolkit for CRISPR-Cas13-based RNA manipulation in Drosophila.
    Huynh N; Depner N; Larson R; King-Jones K
    Genome Biol; 2020 Nov; 21(1):279. PubMed ID: 33203452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.